These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12161073)

  • 21. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.
    Olson ST; Richard B; Izaguirre G; Schedin-Weiss S; Gettins PG
    Biochimie; 2010 Nov; 92(11):1587-96. PubMed ID: 20685328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.
    Schedin-Weiss S; Richard B; Olson ST
    Arch Biochem Biophys; 2010 Dec; 504(2):169-76. PubMed ID: 20816747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
    Schedin-Weiss S; Richard B; Hjelm R; Olson ST
    Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation.
    Monien BH; Krishnasamy C; Olson ST; Desai UR
    Biochemistry; 2005 Sep; 44(35):11660-8. PubMed ID: 16128566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators.
    Gunnarsson GT; Desai UR
    J Med Chem; 2002 Sep; 45(20):4460-70. PubMed ID: 12238925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
    Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity.
    Navarro-Fernández J; Pérez-Sánchez H; Martínez-Martínez I; Meliciani I; Guerrero JA; Vicente V; Corral J; Wenzel W
    J Med Chem; 2012 Jul; 55(14):6403-12. PubMed ID: 22742452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
    Meagher JL; Huntington JA; Fan B; Gettins PG
    J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity.
    McCoy AJ; Pei XY; Skinner R; Abrahams JP; Carrell RW
    J Mol Biol; 2003 Feb; 326(3):823-33. PubMed ID: 12581643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanisms of the Impaired Heparin Pentasaccharide Interactions in 10 Antithrombin Heparin Binding Site Mutants Revealed by Enhanced Sampling Molecular Dynamics.
    Balogh G; Bereczky Z
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
    Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
    J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid.
    Elli S; Stancanelli E; Wang Z; Petitou M; Liu J; Guerrini M
    Chemistry; 2020 Sep; 26(51):11814-11818. PubMed ID: 32515841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
    Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
    J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.